Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Hungary has been on the rise in recent years.
Customer preferences: Hungarian consumers have shown a growing interest in dermatological drugs due to the increasing prevalence of skin diseases and disorders. Additionally, the rising awareness about the importance of skincare and the availability of a wide range of products in the market have contributed to the growth of the dermatological drugs market in Hungary.
Trends in the market: One of the significant trends in the Hungarian dermatological drugs market is the increasing demand for topical drugs. These drugs are gaining popularity due to their ease of use and effectiveness in treating skin disorders. Moreover, the growing preference for natural and organic products has led to the development of new dermatological drugs that are free from harmful chemicals.
Local special circumstances: Hungary has a high prevalence of skin diseases due to the country's geographical location and climate. The harsh winters and hot summers in Hungary can cause various skin problems, such as dryness, eczema, and psoriasis. As a result, the demand for dermatological drugs has been increasing steadily over the years.
Underlying macroeconomic factors: The Hungarian economy has been growing steadily, which has led to an increase in disposable income and healthcare spending. The government's efforts to improve the healthcare sector have also contributed to the growth of the dermatological drugs market. Additionally, the presence of a large number of pharmaceutical companies in Hungary has led to the development of new and innovative dermatological drugs.In conclusion, the Hungarian dermatological drugs market is growing at a steady pace due to the increasing prevalence of skin diseases, rising awareness about skincare, and the availability of a wide range of products in the market. The demand for topical drugs and natural and organic products is also on the rise. The harsh climate in Hungary has contributed to the high prevalence of skin diseases, making dermatological drugs an essential part of the healthcare sector. The growing economy and government initiatives to improve healthcare have also played a significant role in the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
